Cargando…

Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis

BACKGROUND: Genetics play an important role in risk for cardiometabolic diseases—including type 2 diabetes, cardiovascular disease and obesity. Existing research has explored the clinical utility of genetic risk tools such as polygenic risk scores—and whether interventions communicating genetic risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Jing Hui, Sultan, Najia, Finer, Sarah, Fudge, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641935/
https://www.ncbi.nlm.nih.gov/pubmed/37953248
http://dx.doi.org/10.1186/s12916-023-03150-9
_version_ 1785146855480360960
author Law, Jing Hui
Sultan, Najia
Finer, Sarah
Fudge, Nina
author_facet Law, Jing Hui
Sultan, Najia
Finer, Sarah
Fudge, Nina
author_sort Law, Jing Hui
collection PubMed
description BACKGROUND: Genetics play an important role in risk for cardiometabolic diseases—including type 2 diabetes, cardiovascular disease and obesity. Existing research has explored the clinical utility of genetic risk tools such as polygenic risk scores—and whether interventions communicating genetic risk information using these tools can impact on individuals’ cognitive appraisals of disease risk and/or preventative health behaviours. Previous systematic reviews suggest mixed results. To expand current understanding and address knowledge gaps, we undertook an interpretive, reflexive method of evidence synthesis—questioning the theoretical basis behind current interventions that communicate genetic risk information and exploring how the effects of genetic risk tools can be fully harnessed for cardiometabolic diseases. METHODS: We obtained 189 records from a combination of database, website and grey literature searches—supplemented with reference chaining and expert subject knowledge within the review team. Using pre-defined critical interpretive synthesis methods, quantitative and qualitative evidence was synthesised and critiqued alongside theoretical understanding from surrounding fields of behavioural and social sciences. FINDINGS: Existing interventions communicating genetic risk information focus predominantly on the “self”, targeting individual-level cognitive appraisals, such as perceived risk and perceived behavioural control. This approach risks neglecting the role of contextual factors and upstream determinants that can reinforce individuals’ interpretations of risk. It also assumes target populations to embody an “ascetic subject of compliance”—the idea of a patient who strives to comply diligently with professional medical advice, logically and rationally adopting any recommended lifestyle changes. We developed a synthesising argument—“beyond the ascetic subject of compliance”—grounded in three major limitations of this perspective: (1) difficulty applying existing theories/models to diverse populations, (2) the role of familial variables and (3) the need for a life course perspective. CONCLUSIONS: Interventions communicating genetic risk information should account for wider influences that can affect individuals’ responses to risk at different levels—including through interactions with their family systems, socio-cultural environments and wider health provision. PROTOCOL REGISTRATION: PROSPERO CRD42021289269 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-03150-9.
format Online
Article
Text
id pubmed-10641935
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106419352023-11-14 Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis Law, Jing Hui Sultan, Najia Finer, Sarah Fudge, Nina BMC Med Research Article BACKGROUND: Genetics play an important role in risk for cardiometabolic diseases—including type 2 diabetes, cardiovascular disease and obesity. Existing research has explored the clinical utility of genetic risk tools such as polygenic risk scores—and whether interventions communicating genetic risk information using these tools can impact on individuals’ cognitive appraisals of disease risk and/or preventative health behaviours. Previous systematic reviews suggest mixed results. To expand current understanding and address knowledge gaps, we undertook an interpretive, reflexive method of evidence synthesis—questioning the theoretical basis behind current interventions that communicate genetic risk information and exploring how the effects of genetic risk tools can be fully harnessed for cardiometabolic diseases. METHODS: We obtained 189 records from a combination of database, website and grey literature searches—supplemented with reference chaining and expert subject knowledge within the review team. Using pre-defined critical interpretive synthesis methods, quantitative and qualitative evidence was synthesised and critiqued alongside theoretical understanding from surrounding fields of behavioural and social sciences. FINDINGS: Existing interventions communicating genetic risk information focus predominantly on the “self”, targeting individual-level cognitive appraisals, such as perceived risk and perceived behavioural control. This approach risks neglecting the role of contextual factors and upstream determinants that can reinforce individuals’ interpretations of risk. It also assumes target populations to embody an “ascetic subject of compliance”—the idea of a patient who strives to comply diligently with professional medical advice, logically and rationally adopting any recommended lifestyle changes. We developed a synthesising argument—“beyond the ascetic subject of compliance”—grounded in three major limitations of this perspective: (1) difficulty applying existing theories/models to diverse populations, (2) the role of familial variables and (3) the need for a life course perspective. CONCLUSIONS: Interventions communicating genetic risk information should account for wider influences that can affect individuals’ responses to risk at different levels—including through interactions with their family systems, socio-cultural environments and wider health provision. PROTOCOL REGISTRATION: PROSPERO CRD42021289269 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-03150-9. BioMed Central 2023-11-13 /pmc/articles/PMC10641935/ /pubmed/37953248 http://dx.doi.org/10.1186/s12916-023-03150-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Law, Jing Hui
Sultan, Najia
Finer, Sarah
Fudge, Nina
Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis
title Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis
title_full Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis
title_fullStr Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis
title_full_unstemmed Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis
title_short Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis
title_sort advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641935/
https://www.ncbi.nlm.nih.gov/pubmed/37953248
http://dx.doi.org/10.1186/s12916-023-03150-9
work_keys_str_mv AT lawjinghui advancingthecommunicationofgeneticriskforcardiometabolicdiseasesacriticalinterpretivesynthesis
AT sultannajia advancingthecommunicationofgeneticriskforcardiometabolicdiseasesacriticalinterpretivesynthesis
AT finersarah advancingthecommunicationofgeneticriskforcardiometabolicdiseasesacriticalinterpretivesynthesis
AT fudgenina advancingthecommunicationofgeneticriskforcardiometabolicdiseasesacriticalinterpretivesynthesis